A genomic "roadmap" to "better" drugs.

Abstract excerpt

Utilization of pharmacogenomic information has the potential to significantly improve treatment outcome and markedly reduce the rate of attrition of drugs in clinical development. A major gap that limits our ability to utilize pharmacogenomic information in drug discovery, drug development or clinical practice is that we often do not know the genetic variants responsible for inter-individual differences in drug...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biotransformation
• Share to Computational Biology
• Share to Drug Design